While it may slightly improve body composition and energy levels, long-term sustainable weight loss is built on consistent habits eating a balanced diet rich in whole foods, managing stress, moving regularly, and getting adequate rest
Friebolin W, Jannack B, Wenzel N et al (2008) Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum
PlexusDx patients achieve comparable weight loss results while paying $149-$189/month (depending on commitment tier) versus $900$1,500 monthly for Wegovy
Continued improvement with consistent use
Similar to the GLP-1 analogues discussed previously, pramlintide is currently approved for the treatment of type 1 and type 2 diabetes
MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
